Home > > > > Report Detail

Global Influenza Drugs and Vaccines Market – By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis By Region, By Country: Opportunities and Forecast (2016-2021) - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, China, India, Japan)

Publisher Name :
Date: 25-May-2017
No. of pages: 164

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Influenza Market on the basis of Segment Type (Vaccine and Drugs), By Vaccine (Trivalent and Quadrivalent), By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Region (North America, Europe, APAC and ROW) and By Country (U.S., Canada, U.K., Germany, France, China, India, Japan).

Rising awareness in relation to influenza virus, surging investment by companies in R&D and increasing number of immunization programmes organized by the government have been some of the factors backing the growth of Global Influenza Market.

According to Azoth Analytics research report, “Global Influenza Drugs and Vaccines Market – By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis By Region, By Country: Opportunities and Forecast (2016-2021) - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, China, India, Japan)”, global market is projected to display a steady growth rate represented by a CAGR of 10.24% during 2017 – 2022, chiefly driven by increasing spending over various immunization programmes.

The report titled “Global Influenza Drugs and Vaccines Market – By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis By Region, By Country: Opportunities and Forecast (2016-2021) - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, China, India, Japan)”, has covered and analysed the potential of Global Influenza Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global influenza market. Additionally, the report also highlights key development and new drugs launched by various companies across the globe.

Scope of the Report

Global Influenza Market


  • (Actual Period: 2012-2016E, Forecast Period: 2017-2022)

  • By Segment Type: Influenza Vaccine Market, Influenza Drugs Market

  • By Vaccine Type: Trivalent, Quadrivalent

  • By Drug Type: Zanamivi, Oseltamivir Phosphate, Peramivir


Regional Markets – North America, Europe, APAC, RoW


  • (Actual Period: 2012-2016E, Forecast Period: 2017-2022)

  • By Segment Type: Influenza Vaccine Market, Influenza Drugs Market

  • By Vaccine Type: Trivalent, Quadrivalent

  • By Drug Type: Zanamivi, Oseltamivir Phosphate, Peramivir


Country Analysis - US, Canada, UK, Germany, France, Japan, China, India


  • (Actual Period: 2012-2016E, Forecast Period: 2017-2022)

  • By Segment Type: Influenza Vaccine Market, Influenza Drugs Market


Other Report Highlights


  • Market Dynamics – Trends, Drivers, Challenges

  • Pipeline Analysis

  • Company Analysis - Falvogen, Gilead Science and  Bio Cryst


Customization of the Report

The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research. 

Global Influenza Drugs and Vaccines Market – By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis By Region, By Country: Opportunities and Forecast (2016-2021) - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, China, India, Japan)

Table of Contents

1. Influenza Market: An Introduction
1.1. Research Methodology
1.2. Executive Summary
1.3. Strategic Recommendations
1.4. Product Overview

2. Global Influenza Market Overview
2.1. Global Influenza Market Size, By Value, Historic, 2011-2015
2.2. Global Influenza Market Size, By Value, Forecast, 2016-2021

3. Global Influenza Market: Product Analysis
3.1. By Product-Actual(2015)
3.2. By Product-Forecast(2021)
3.3. Global Influenza Therapeutics Market , Historic,  2011-2015
3.4. Global Influenza Therapeutics Market , Forecast,  2016-21
3.5. Global Influenza Vaccines Market, Historic, 2011-16
3.6. Global Influenza Vaccines Market, Forecast, 2016-2021
3.7. Global Influenza Therapeutics Market, By Drug Type
3.7.1. Global Zanamivir Market , Historic, 2011-2015
3.7.2. Global Zanamivir Market , Forecast, 2016-2021
3.7.3. Global Oseltamivir Phosphate  Market ,   Historic, 2011-2015
3.7.4. Global Oseltamivir Phosphate  Market , Forecast, 2016-2021
3.7.5. Global Peramivir Market , Forecast, 2016-2021
3.8. Global Influenza Vaccines Market, By Vaccine Type
3.8.1. Global Trivalent Vaccines Market , Historic, 2011-2015
3.8.2. Global Trivalent Vaccines Market , Forecast, 2016-2021
3.8.3. Global Quadrivalent Vaccines Market ,   Historic, 2011-2015
3.8.4. Global Quadrivalent Vaccines Market , Forecast, 2016-2021

4. Global Influenza Vaccines & Drugs - Pipeline Analysis

5. Global Influenza Market, Breakdown By Region
5.1. By Region-Actual(2015)
5.2. By Region-Forecast(2021)

6. North America Influenza Market: An Analysis
6.1. North America Influenza Market Size, By Value, Historic,  2011-2015
6.2. North America Influenza Market Size, By Value, Forecast,  2016-2021
6.3. North America Influenza Therapeutics Market Size, By Value, Historic,  2011-2015
6.4. North America Influenza Therapeutics Market Size, By Value, Forecast , 2016-2021
6.5. North America Influenza Vaccines Market Size, By Value, Historic  2011-2015
6.6. North America Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
6.7. North America Influenza Therapeutics: Segment Analysis
6.8. North America Influenza Therapeutics Market, By Drug Type, Historic, 2011-2015
6.9. North America Influenza Therapeutics Market, By Drug Type, Forecast, 2016-2021
6.10. North America Influenza Vaccines: Segment Analysis
6.11. North America Influenza Vaccines Market, By Vaccine Type, Historic, 2011-2015
6.12. North America Influenza Vaccines Market, By Vaccine Type, Forecast, 2016-2021

7. United States Influenza Market: An Analysis
7.1. United States Influenza Market Size, By Value, Historic,  2011-2015
7.2. United States Influenza Market Size, By Value, Forecast, 2016-2021
7.3. United States Influenza Therapeutics Market Size, By Value, Historic  2011-2015
7.4. United States Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
7.5. United States Influenza Vaccines Market Size, By Value, Historic  2011-2015
7.6. United States Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
7.7. Canada Influenza Market Size, By Value, Historic,  2011-2015
7.8. Canada Influenza Market Size, By Value, Forecast, 2016-2021
7.9. Canada Influenza Therapeutics Market Size, By Value, Historic  2011-2015
7.10. Canada Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
7.11. Canada Influenza Vaccines Market Size, By Value, Historic  2011-2015
7.12. Canada Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
7.13. North America Other Influenza Market Size, By Value, Historic,  2011-2015
7.14. North America Other Influenza Market Size, By Value, Forecast,  2016-2021

8. Europe Influenza Market: An Analysis
8.1. Europe Influenza Market Size, By Value, Historic,  2011-2015
8.2. Europe Influenza Market Size, By Value, Forecast,  2016-2021
8.3. Europe Influenza Therapeutics Market Size, By Value, Historic,  2011-2015
8.4. Europe Influenza Therapeutics Market Size, By Value, Forecast , 2016-2021
8.5. Europe Influenza Vaccines Market Size, By Value, Historic  2011-2015
8.6. Europe Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
8.7. Europe Influenza Therapeutics: Segment Analysis
8.8. Europe Influenza Therapeutics Market, By Drug Type, Historic, 2011-2015
8.9. Europe Influenza Therapeutics Market, By Drug Type, Forecast, 2016-2021
8.10. Europe Influenza Vaccines: Segment Analysis
8.11. Europe Influenza Vaccines Market, By Vaccine Type, Historic, 2011-2015
8.12. Europe Influenza Vaccines Market, By Vaccine Type, Forecast, 2016-2021

9. United Kingdom Influenza Market: An Analysis
9.1. United Kingdom Influenza Market Size, By Value, Historic,  2011-2015
9.2. United Kingdom  Influenza Market Size, By Value, Forecast, 2016-2021
9.3. United Kingdom  Influenza Therapeutics Market Size, By Value, Historic  2011-2015
9.4. United Kingdom  Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
9.5. United Kingdom  Influenza Vaccines Market Size, By Value, Historic  2011-2015
9.6. United Kingdom  Influenza Vaccines Market Size, By Value, Forecast, 2016-2021

10. France Influenza Market: An Analysis
10.1. France Influenza Market Size, By Value, Historic,  2011-2015
10.2. France Influenza Market Size, By Value, Forecast, 2016-2021
10.3. France Influenza Therapeutics Market Size, By Value, Historic  2011-2015
10.4. France  Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
10.5. France   Influenza Vaccines Market Size, By Value, Historic  2011-2015
10.6. France  Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
10.7. Europe Other Influenza Market Size, By Value, Forecast,  2011-2015
10.8. Europe Other Influenza Market Size, By Value, Forecast,  2016-2021

11. APAC Influenza Market: An Analysis
11.1. APAC Influenza Market Size, By Value, Historic,  2011-2015
11.2. APAC Influenza Market Size, By Value, Forecast,  2016-2021
11.3. APAC Influenza Therapeutics Market Size, By Value, Historic,  2011-2015
11.4. APAC Influenza Therapeutics Market Size, By Value, Forecast , 2016-2021
11.5. APAC Influenza Vaccines Market Size, By Value, Historic  2011-2015
11.6. APAC Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
11.7. APAC Influenza Therapeutics: Segment Analysis
11.8. APAC Influenza Therapeutics Market, By Drug Type, Historic, 2011-2015
11.9. APAC Influenza Therapeutics Market, By Drug Type, Forecast, 2016-2021
11.10. APAC Influenza Vaccines: Segment Analysis
11.11. APAC Influenza Vaccines Market, By Vaccine Type, Historic, 2011-2015
11.12. APAC Influenza Vaccines Market, By Vaccine Type, Forecast, 2016-2021

12. India Influenza Market: An Analysis
12.1. India Influenza Market Size, By Value, Historic,  2011-2015
12.2. India Influenza Market Size, By Value, Forecast, 2016-2021
12.3. India Influenza Therapeutics Market Size, By Value, Historic  2011-2015
12.4. India Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
12.5. India Influenza Vaccines Market Size, By Value, Historic  2011-2015
12.6. India  Influenza Vaccines Market Size, By Value, Forecast, 2016-2021

13. China Influenza Market: An Analysis
13.1. China Influenza Market Size, By Value, Historic,  2011-2015
13.2. China Influenza Market Size, By Value, Forecast, 2016-2021
13.3. China Influenza Therapeutics Market Size, By Value, Historic  2011-2015
13.4. China Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021
13.5. China Influenza Vaccines Market Size, By Value, Historic  2011-2015
13.6. China  Influenza Vaccines Market Size, By Value, Forecast, 2016-2021
13.7. APAC Other Influenza Market Size, By Value, Historic,  2011-2015
13.8. APAC Other Influenza Market Size, By Value, Forecast,  2016-2021

14. ROW Influenza Market Overview
14.1. ROW Influenza Market Size, By Value, Historic,  2011-2015
14.2. ROW Influenza Market Size, By Value, Historic , 2016-2021

15. Market Dynamics
15.1. Drivers
15.2. Challenges
15.3. Trends

16. Company Profiles
16.1. GlaxoSmithKline
16.2. Sanofi Pasteur, Inc.
16.3. CSL Limited
16.4. Astrazeneca
16.5. Protein Sciences Corporation
16.6. Serum Institute Of India Pvt. Ltd.
16.7. Emergent Biosolutions
16.8. Emergent Biosolutions
16.9. BioCryst Pharmaceuticals.Inc.
16.10. Alvogen

List of Tables

Table A: Influenza Pipe analysis
Table B: Influenza Pipe analysis

List of Figures

Figure 1: Global Influenza Market Size, By Value, 2011-2015 (USD Billion)
Figure 2: Global Influenza Market Size, By Value, 2016E-2021F (USD Billion)
Figure 3: Global Influenza Market  Size and Share, By Product, 2015
Figure 4: Key Drivers
Figure 5: Global Influenza Market  Size and Share, By Product, 2021F
Figure 6: Key Drivers
Figure 7: Global Influenza Therapeutics  Market Size, By Value, 2011-2015 (USD Billion)
Figure 8: Global Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion)
Figure 9: Global Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 10: Global Influenza Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 11: Global Zanamivir Market Size, By Value, 2011-2015 (USD Billion)
Figure 12: Global Zanamivir Market Size, By Value, 2016E-2021F (USD Billion)
Figure 13: Global Oseltamivir Phosphate Market Size, By Value, 2011-2015 (USD Billion)
Figure 14: Global Oseltamivir Phosphate Market Size, By Value, 2016E-2021F (USD Billion)
Figure 15: Global Peramivir Market Size, By Value, 2016E-2021F (USD Billion)
Figure 16: Global Trivalent Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 17: Global Trivalent Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 18: Global Quadrivalent Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 19: Global Quadrivalent Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 20: Global Influenza Market  Size and Share, By Region, 2015
Figure 21:  Key Drivers
Figure 22: Global Influenza  Market  Size and Share, By Region, 2021F
Figure 23: Key Drivers
Figure 24: North America  Influenza Market Size, By Value, 2011-2015 (USD Billion
Figure 25: North America  Influenza Market Size, By Value, 2016E-2021F (USD Billion)
Figure 26: North America  Influenza Therapeutics  Market Size, By Value, 2011-2015 (USD Billion)
Figure 27: North America  Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion)
Figure 28: North America Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 29: North America Influenza Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 30: North America Influenza Therapeutics Market: By Product, By Value, 2011-2015 (USD Billion)
Figure 31: North America Influenza Therapeutics Market: By Therapeutics Type, By Value, 2016E-2021F (USD Billion)
Figure 32: North America Influenza Vaccines Market: By Product Type, By Value, 2011-2015 (USD Billion)
Figure 33: North America Influenza Vaccines Market: By Product, By Value, 2016E-2021F (USD Billion)
Figure 34: US Influenza Market Size, By Value, 2011-2021(USD Billion)
Figure 35: US Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)
Figure 36: US Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 37: Canada Influenza Market Size, By Value, 2011-2021(USD Billion)
Figure 38: Canada Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)
Figure 39: Canada Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 40: North America Others Influenza Market Size, By Value, 2011-2021 (USD Billion)
Figure 41: Europe Influenza Market Size, By Value, 2011-2015 (USD Billion)
Figure 42: Europe Influenza Market Size, By Value, 2016E-2021F (USD Billion)
Figure 43: Europe Influenza Therapeutics  Market Size, By Value, 2011-2015 (USD Billion)
Figure 44: Europe Influenza Therapeutics  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 45: Europe Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 46: Europe Influenza Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 47: Europe Influenza Therapeutics Market: By Product, By Value, 2011-2015 (USD Billion)
Figure 48: Europe Influenza Therapeutics Market: By Therapeutics Type, By Value, 2016E-2021F (USD Billion)
Figure 49: Europe Influenza Vaccines Market: By Product Type, By Value, 2011-2015 (USD Billion)
Figure 50: Europe Influenza Vaccines Market: By Product, By Value, 2016E-2021F (USD Billion)
Figure 51: UK Influenza Market Size, By Value, 2011-2021(USD Billion)
Figure 52: UK Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)
Figure 53: UK Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 54: France Influenza Market Size, By Value, 2011-2021(USD Billion)
Figure 55: France Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)
Figure 56: France Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 57: Europe  Others Influenza Market Size, By Value, 2011-2021 (USD Billion)
Figure 58: APAC Influenza Market Size, By Value, 2011-2015 (USD Billion)
Figure 59: APAC Influenza Market Size, By Value, 2016E-2021F (USD Billion)
Figure 60: APAC Influenza Therapeutics Market Size, By Value, 2011-2015 (USD Billion)
Figure 61: APAC Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion)
Figure 62: APAC Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 63: APAC Influenza Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 64: APAC Influenza Therapeutics Market: By Product, By Value, 2011-2015 (USD Billion)
Figure 65: APAC Influenza Therapeutics Market: By Therapeutics Type, By Value, 2016E-2021F (USD Billion)
Figure 66: APAC Influenza Vaccines Market: By Product Type, By Value, 2011-2015 (USD Billion)
Figure 67: APAC Influenza Vaccines Market: By Product, By Value, 2016E-2021F (USD Billion)
Figure 68: India Influenza Market Size, By Value, 2011-2021(USD Billion)
Figure 69: India Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)
Figure 70: India Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 71: China Influenza Market Size, By Value, 2011-2021(USD Billion)
Figure 72: China Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)
Figure 73: China Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 74: APAC  Others Influenza Market Size, By Value, 2011-2021 (USD Billion)
Figure 75: ROW Influenza Market Size, By Value, 2011-2015 (USD Million)
Figure 76: ROW Influenza Market Size, By Value, 2016E-2021F (USD Million)

  • Global Encephalitis Vaccination Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102
    According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......
  • Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......
  • Global Avian Influenza Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155
    According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......
  • Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......
  • Global Influenza Vaccine Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......
  • Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117
    Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
  • Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......
  • 2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel
    Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107
    This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs